O&G open
O&G open
Audio Summaries
Every issue of O&G open moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from O&G open.
Interstitial Molar Ectopic Pregnancy Despite Euploid Embryo Transfer: A Case Report.
Nov 11, 2026
This case report describes a 36-year-old woman who developed a right interstitial molar ectopic pregnancy after frozen transfer of a female, euploid embryo selected by PGT-A, despite no apparent abnormality in the embryo. The authors examine how a molar pregnancy could arise in this setting, pointing to the limitation that standard PGT-A can miss paternal-origin triploidy without SNP-based testing, as well as the possibility of spontaneous fertilization during ART treatment. The patient was managed with laparoscopic right cornual resection, and the authors conclude that laboratory variability in PGT-A testing and human factors such as unprotected intercourse during treatment may contribute to unexpected outcomes.
The Association Between Glucose Intolerance and Longitudinal Fetal Growth in Nulliparas.
Oct 28, 2026
This secondary analysis of the NuMoM2b cohort of 7,010 nulliparous individuals asked how glucose intolerance (normal, mild glucose intolerance, or gestational diabetes) relates to fetal growth from midgestation to delivery. Fetal overgrowth tracked with glucose intolerance beginning around 22-29 weeks, and by delivery mild glucose intolerance doubled the odds of large-for-gestational-age birth (AOR 2.00), whereas GDM carried no significantly increased LGA risk (AOR 1.34, CI crossing 1). The authors suggest that the increased surveillance and management triggered by a GDM diagnosis may blunt excess fetal growth, and they note that whether treating mild glucose intolerance reduces LGA risk remains unknown.
An Evaluation of Perinatal Human Immunodeficiency Virus Transmissions in New York State, 2007-2020.
Oct 23, 2026
This retrospective cohort study of 5,722 birthing parent-infant pairs in New York State (2007-2020) asked which factors predict perinatal HIV transmission and unsuppressed viral load near delivery. Perinatal transmission occurred in 0.77% of infants, and an unsuppressed viral load close to delivery was the strongest predictor (adjusted OR 10.47). Illicit substance use, not taking antiretroviral therapy during pregnancy, and late initiation of prenatal care were key factors linked to unsuppressed viral load.
Long-Acting Injectable Buprenorphine in Pregnancy.
Oct 23, 2026
This retrospective chart review of 12 pregnant individuals at one academic medical center asked how long-acting injectable buprenorphine (mostly monthly formulations) is used in practice, particularly among those initiating it during pregnancy after nonprescribed fentanyl use. Ten of the 12 started the medication during pregnancy via low-dose buprenorphine initiation, and retention on any opioid use disorder medication at delivery was high (91.7%), though 66.7% remained on the injectable itself and four patients switched to methadone. The authors conclude that LAI buprenorphine can be used successfully in this population with supplemental sublingual buprenorphine commonly prescribed, and that individualized care is important given the small sample size.
Menopause Education in Obstetrics and Gynecology Residency Training: A Scoping Review.
Oct 15, 2026
This scoping review asked how well obstetrics and gynecology residents are trained in menopause care and how knowledgeable and comfortable they feel managing menopausal patients. Searching three databases and screening 63 articles, the authors identified nine eligible studies and found that residents report limited knowledge and comfort, with little recent evidence that educational interventions have closed this gap despite CREOG objectives. The authors call on residency program leaders to identify curricular gaps and design, implement, and evaluate menopause education aligned with those objectives.
Prenatal Remote Blood Pressure Monitoring and Detection of Chronic Hypertension.
Oct 15, 2026
This retrospective cohort study asked whether enrolling pregnant patients in a universal prenatal remote blood pressure monitoring program starting at the first prenatal visit is linked to more diagnoses of chronic hypertension before 20 weeks of gestation than usual care. After 2:1 propensity score matching of 1,521 patients, those enrolled in remote monitoring had about 68% higher odds of a chronic hypertension diagnosis (OR 1.68, 95% CI 1.10-2.57), with predicted probabilities of 8.5% versus 5.2%. The authors conclude that remote monitoring enables earlier, condition-specific management, though the observational design means this association cannot establish causation.
Pregnancy After Laparoscopic Radiofrequency Ablation: A Case Report.
Oct 15, 2026
This case report describes a 29-year-old woman who conceived spontaneously two years after laparoscopic radiofrequency ablation of a small uterine fibroid and presented at 17 weeks with an anterior fundal uterine rupture, which was surgically repaired. The authors examine whether this uterine-sparing procedure poses reproductive risks, particularly rupture, and conclude that while such rupture is rare, it should be discussed with patients during counseling and warrants more prospective study.
Comparative Effectiveness of Empiric Antibiotics for Uncomplicated Urinary Tract Infection in Postmenopausal Women.
Oct 2, 2026
This retrospective TriNetX cohort study asked how empiric nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), and fosfomycin compare in postmenopausal women with uncomplicated UTI, using a composite 7-day treatment failure outcome (escalation, pyelonephritis, bacteremia, sepsis, hospitalization, critical care, or death) across 236,927 propensity-matched patients. TMP-SMX was associated with higher composite failure than nitrofurantoin (10.2% vs 8.0%) and fosfomycin (13.3% vs 9.6%), while nitrofurantoin and fosfomycin had similar overall failure rates, though hospitalization was less frequent with nitrofurantoin. Because the study is observational, these associations may be affected by residual confounding, but they suggest TMP-SMX may be a less favorable empiric choice in this population.
Effects of Abortion Bans on the Physician Workforce.
Sep 30, 2026
This qualitative study asked how abortion bans affect physicians providing early pregnancy care and the broader reproductive health workforce. Through interviews with 55 obstetrician-gynecologists, emergency medicine physicians, and family medicine physicians in 14 states with total or near-total bans, the authors found that bans created clinical uncertainty, narrowed the services physicians felt able to offer, and contributed to burnout and ethical strain. Participants also reported harms to training and recruitment, suggesting that these laws may weaken the reproductive health workforce beyond abortion care itself.
Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy.
Sep 26, 2026
This case report describes two pregnant patients on buprenorphine/naloxone whose urine drug screens unexpectedly presumed positive for opiates, prompting the question of whether this reflected return to opioid use. Confirmatory testing revealed only low-level noroxymorphone (46 and 79 ng/mL) with no detectable parent opioids, indicating it arose from naloxone metabolism rather than illicit or prescribed opioid use. The authors conclude that clinicians should recognize naloxone-derived noroxymorphone to avoid misclassifying patients and causing distress, including potential child welfare consequences.
